Trending

24/7 MN (NASDAQ: SLNO) SOLENO THERAPEUDICS INC. shares are on the move this morning as they announced further communications with the FDA concerning a randomized withdrawal period.

The stock is up more than 45% as of this post and is trading at .27 on more than 5600 trades and 6.8 million in volume as of this post

Soleno Therapeutics Provides Regulatory Update on DCCR for the Treatment of Prader-Willi Syndrome

https://finance.yahoo.com/news/soleno-therapeutics-provides-regulatory-dccr-120000797.html

RelatedNews

Signup today for free and be the first to get notified of breaking news.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

SIGN UP FOR OUR NEWSLETTER

Sign up for Breaking Alerts, our newsletter putting timely and updated stock and crypto markets news into your hands.

Add New Playlist